BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9596579)

  • 1. Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase.
    Camps M; Nichols A; Gillieron C; Antonsson B; Muda M; Chabert C; Boschert U; Arkinstall S
    Science; 1998 May; 280(5367):1262-5. PubMed ID: 9596579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mitogen-activated protein kinase phosphatase is an important negative regulator of lipopolysaccharide-mediated c-Jun N-terminal kinase activation in mouse macrophage cell lines.
    Matsuguchi T; Musikacharoen T; Johnson TR; Kraft AS; Yoshikai Y
    Mol Cell Biol; 2001 Oct; 21(20):6999-7009. PubMed ID: 11564882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific inactivation and nuclear anchoring of extracellular signal-regulated kinase 2 by the inducible dual-specificity protein phosphatase DUSP5.
    Mandl M; Slack DN; Keyse SM
    Mol Cell Biol; 2005 Mar; 25(5):1830-45. PubMed ID: 15713638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of intrinsically active (MEK-independent) variants of the ERK family of mitogen-activated protein (MAP) kinases.
    Levin-Salomon V; Kogan K; Ahn NG; Livnah O; Engelberg D
    J Biol Chem; 2008 Dec; 283(50):34500-10. PubMed ID: 18829462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of kinase-interaction-motif protein tyrosine phosphatases with the mitogen-activated protein kinase ERK2.
    Francis DM; Koveal D; Tortajada A; Page R; Peti W
    PLoS One; 2014; 9(3):e91934. PubMed ID: 24637728
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Kumar GS; Page R; Peti W
    Biomol NMR Assign; 2021 Oct; 15(2):243-248. PubMed ID: 34101142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of high-content assay for inhibitors of mitogen-activated protein kinase phosphatases.
    Vogt A; Lazo JS
    Methods; 2007 Jul; 42(3):268-77. PubMed ID: 17532514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional divergence caused by mutations in an energetic hotspot in ERK2.
    Taylor CA; Cormier KW; Keenan SE; Earnest S; Stippec S; Wichaidit C; Juang YC; Wang J; Shvartsman SY; Goldsmith EJ; Cobb MH
    Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15514-15523. PubMed ID: 31296562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. There's more to death than life: Noncatalytic functions in kinase and pseudokinase signaling.
    Mace PD; Murphy JM
    J Biol Chem; 2021; 296():100705. PubMed ID: 33895136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARP1 as an Epigenetic Modulator: Implications for the Regulation of Host-Viral Dynamics.
    Sobotka AA; Tempera I
    Pathogens; 2024 Jan; 13(2):. PubMed ID: 38392869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Navigating the ERK1/2 MAPK Cascade.
    Martin-Vega A; Cobb MH
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slik maintains tissue homeostasis by preventing JNK-mediated apoptosis.
    Li C; Zhu X; Sun X; Guo X; Li W; Chen P; Shidlovskii YV; Zhou Q; Xue L
    Cell Div; 2023 Oct; 18(1):16. PubMed ID: 37794497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERK1/2 inhibitors act as monovalent degraders inducing ubiquitylation and proteasome-dependent turnover of ERK2, but not ERK1.
    Balmanno K; Kidger AM; Byrne DP; Sale MJ; Nassman N; Eyers PA; Cook SJ
    Biochem J; 2023 May; 480(9):587-605. PubMed ID: 37018014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sprouty4 at the crossroads of Trk neurotrophin receptor signaling suppression by glucocorticoids.
    Ferrero Restelli F; Federicci F; Ledda F; Paratcha G
    Front Mol Neurosci; 2023; 16():1090824. PubMed ID: 36818650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogen-Activated Protein Kinase Phosphatases: No Longer Undruggable?
    Shillingford SR; Bennett AM
    Annu Rev Pharmacol Toxicol; 2023 Jan; 63():617-636. PubMed ID: 36662585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual specificity phosphatase 7 drives the formation of cardiac mesoderm in mouse embryonic stem cells.
    Sladeček S; Radaszkiewicz KA; Bőhmová M; Gybeľ T; Radaszkiewicz TW; Pacherník J
    PLoS One; 2022; 17(10):e0275860. PubMed ID: 36227898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological attenuation of melanoma by tryptanthrin pertains to the suppression of MITF-M through MEK/ERK signaling axis.
    Shabna A; Antony J; Vijayakurup V; Saikia M; Liju VB; Retnakumari AP; Amrutha NA; Alex VV; Swetha M; Aiswarya SU; Jannet S; Unni US; Sundaram S; Sherin DR; Anto NP; Bava SV; Chittalakkottu S; Ran S; Anto RJ
    Cell Mol Life Sci; 2022 Aug; 79(9):478. PubMed ID: 35948813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERK1b, a 46-kDa ERK isoform that is differentially regulated by MEK.
    Yung Y; Yao Z; Hanoch T; Seger R
    Cell Biol Int; 2022 Jul; 46(7):1021-1035. PubMed ID: 35332606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of bFGF-induced effects on rat aortic smooth muscle cells by β
    Chang Y; Dagat LA; Yusuf A; Zahriya Y; Staputyte K; Worley E; Holt A; Canuteson N; Messieha V; Halila K
    Curr Res Pharmacol Drug Discov; 2022; 3():100094. PubMed ID: 35300074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DUSP9, a Dual-Specificity Phosphatase with a Key Role in Cell Biology and Human Diseases.
    Khoubai FZ; Grosset CF
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.